Ibrahim H. Altiparmak

Harran, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Evaluation of Soluble ST2 and Galectin-3 Levels in Patients with Heart Failure.

Evaluation of Soluble ST2 and Galectin-3 Levels in Patients with Heart Failure.

Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Published: January 21, 2026

Protective Effects of Riociguat Against Contrast-Induced Nephropathy: An Experimental and Machine Learning-Based Study in Rats.

Protective Effects of Riociguat Against Contrast-Induced Nephropathy: An Experimental and Machine Learning-Based Study in Rats.

Journal: The Kaohsiung journal of medical sciences

Published: December 20, 2025

Reply to Letter to the Editor: Determining ECG Parameters for Electrical Risk Score in Patients with Non-ST Elevation Myocardial Infarction.

Reply to Letter to the Editor: Determining ECG Parameters for Electrical Risk Score in Patients with Non-ST Elevation Myocardial Infarction.

Journal: Anatolian journal of cardiology

Published: April 18, 2025

The Association of Electrical Risk Score with Prognosis in Patients with Non-ST Elevation Myocardial Infarction Undergoing Coronary Angiography.

The Association of Electrical Risk Score with Prognosis in Patients with Non-ST Elevation Myocardial Infarction Undergoing Coronary Angiography.

Journal: Anatolian journal of cardiology

Published: November 25, 2024

The Association of Neuropeptide Y with the Presence and Frequency of Ventricular Premature Beats.

The Association of Neuropeptide Y with the Presence and Frequency of Ventricular Premature Beats.

Journal: Current cardiology reviews

Published: October 17, 2024

Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction.

Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction.

Journal: Angiology

Published: March 06, 2024

The Effect of CD31 on Coronary Collateral Development.

The Effect of CD31 on Coronary Collateral Development.

Journal: Cardiovascular & hematological agents in medicinal chemistry

Published: February 12, 2024

The non-HDL-C/HDL-C ratio is a strong and independent predictor of the no-reflow phenomenon in patients with ST-elevation myocardial infarction.

The non-HDL-C/HDL-C ratio is a strong and independent predictor of the no-reflow phenomenon in patients with ST-elevation myocardial infarction.

Journal: Acta cardiologica

Published: January 04, 2024

Disruption of the endothelial glycocalyx layer is associated with idiopathic complete atrioventricular block in the elderly population: An observational pilot study.

Disruption of the endothelial glycocalyx layer is associated with idiopathic complete atrioventricular block in the elderly population: An observational pilot study.

Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Published: December 16, 2023

The HbA1c/C-Peptide Ratio is Associated With the No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction.

The HbA1c/C-Peptide Ratio is Associated With the No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction.

Journal: Angiology

Published: November 03, 2023

Comparison of the Effect of Non-HDL-C/HDL-C Ratio on Coronary Slow Flow with Other Non-Traditional Lipid Markers.

Comparison of the Effect of Non-HDL-C/HDL-C Ratio on Coronary Slow Flow with Other Non-Traditional Lipid Markers.

Journal: Acta Cardiologica Sinica

Published: August 08, 2023

Effect of Hand Dominance on Radial Artery Spasm and Occlusion: A Prospective Observational Study.

Effect of Hand Dominance on Radial Artery Spasm and Occlusion: A Prospective Observational Study.

Journal: Angiology

Published: February 06, 2023

Showing 1-12 of 50

Last Updated: 09/26/2026